Biotechnology has long relied on a handful of model microorganisms, such as Escherichia coli and Saccharomyces cerevisiae, whose genetics and physiology are ...

Looking to invest in biotech stocks? Learn what they are, explore top options, and find out how to get started in this fast-growing, exciting industry.

A weekly newsletter focusing on the most important news in health and biotech. Founded at the Massachusetts Institute of ...

Biotechnology companies are coming out of a dark period for the industry. Why has the tide turned and is now a good time to ...

"Biotechnology" is a term commonly applied to the development of new medicines and therapies, the development of genetically modified plants, biofuels, biological treatment, or the production of ...

Biotechnology is a curious marriage of two seemingly disparate worlds. On one end, we have living organisms—wild, unpredictable celestial creations that can probably never be understood or appreciated ...

Explore advancements in biotechnology, from gene editing's ethical dilemmas to synthetic biology's commercial potential and ...

Do you want to be at the forefront of the rapidly growing biotechnology field? Do you want to develop products derived from living organisms and biomolecules? Do you have a passion for biochemistry, ...

Recent advancements in biotechnology have immense potential to help address many global problems; climate change, an aging society, food security, energy security, and infectious diseases.

Updated Phase 1 dose-escalation data (n=58) show VIR-5500 monotherapy has a favorable safety profile and was well tolerated with no dose-limiting toxicities observed to date - Dose-dependent anti-tumo ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the appointment of Timothy Coughlin to its Board of Directors and as Chair of the Audit Committee, effective June 9, 2026. “We are pleased to ...